department of neurology  
  neurological institute of new york entrance  
  Telephone: 212-305-6939 || Principal Location: The Neurological Institute of New York, 710 West 168th Street, New York, NY 10032  
 
 
 

RESEARCH



Our research mission is to improve diagnosis and treatment of Alzheimer disease and disorders of the aging brain. This research involves basic scientific studies of the molecular and genetic basis of neurodegeneration, neuropathological studies, imaging, studies of the brain, and clinical epidemiological and drug trial studies.

TAUB INSTITUTE FOR RESEARCH ON ALZHEIMER DISEASE AND THE AGING BRAIN


Taub Institute - www.alzheimercenter.org

We provide in-patient consultation services for patients with cognitive and behavioral disorders, and staff the Memory Disorders Clinic at the Psychiatric Institute. Research interests in behavioral disorders and dementia primarily focus on degenerative diseases such as Parkinson disease, Alzheimer disease, Huntington disease, and stroke. Neurologic, psychiatric and neuropsychologic functions are assessed. Current projects include studies of dementia in Parkinson disease, use of brain imaging in dementia, clinical trials, and epidemiology of Alzheimer disease and related disorders; natural history of HIV; cognitive performance in children with complex metabolic disorders. Aging and dementia rounds are held weekly at Columbia-Presbyterian Medical Center and monthly at Harlem Hospital Center. The research activities of the Division of Memory and Behavioral Disorders are integrated closely with those of the Sergievsky Center, and all divisional faculty hold appointments in the Sergievsky Center.

THE G.H. SERGIEVSKY CENTER


The Gertrude H. Sergievsky Center - cpmcnet.columbia.edu/dept/sergievsky

The Gertrude H. Sergievsky Center focuses on developmental disorders of the nervous system that affect humans throughout life from the time we are formed by genetic inheritance at conception until the day of our death. The Center's main focus has been integrating epidemiology with genetic analysis and clinical investigation to explore all phases of diseases of the nervous system.

The Gertrude H. Sergievsky Center uses traditional and genetic epidemiologic approaches to the study of neurological disorders. Areas of major interest include adverse reproductive outcomes, epilepsy and seizure disorders, degenerative diseases of the nervous system, developmental disorders of the nervous system, and neurological disorders of major public health impact. Allied disciplines in the health sciences include biostatistics, human genetics, neurology, obstetrics, pediatrics, physiology, psychiatry, psychology, and social sciences. The faculty of a federally funded training program in neuroepidemiology are located primarily within the Sergievsky Center.



DR. KAREN L. BELL



Development of new clinical treatments for Alzheimer disease. Currently conducting research for the prevention of Alzheimer disease in individuals with mild cognitive impairment. Other research interests include understanding barriers that minorities face in receiving clinical care for dementia and cognitive loss, and developing mechanisms to recruit minorities into clinical research.



DR. LAWRENCE S. HONIG



Dr. Honig performs both basic and clinical research involving various aspects of Alzheimer disease, dementia and cognitive dysfunction. His laboratory research focusses on biomarkers in neurodegenerative disease including studies of gene expression in Lewy Body Disease, frontotemporal dementias, and Alzheimer disease, as well as work on genetic and epigenetic markers, the latter involving role of telomeres in biological aging. His clinical research includes both NIH funded research and pharmaceutical company funded clinical trials. He is the director of the Clinical Core of the NIA/NIH-funded Alzheimer Disease Research Center (ADRC) at Columbia University. He is the principal site investigator in a number of ongoing clinical drug trials aimed at Alzheimer disease, as well as in several clinical trials involving molecular neuroimaging.



DR. EDWARD HUEY



Investigations into the neuroanatomical and genetic bases of behavioral, emotional, and cognitive symptoms in frontotemporal dementia and related disorders. Interested in the overlap of neurological and psychiatric disorders. Also interested in developing and testing treatments for frontotemporal dementia and related disorders.



DR. KAREN S. MARDER



Investigations of genetic influences in families of probands with early-onset compared to late-onset Parkinson disease. Multicenter investigation of risk factors for the development of dementia in HIV. Clinical trials of new therapeutic agents in Huntington disease. Longitudinal study of subjects at risk for developing Huntington disease.



DR. RICHARD MAYEUX



Gertrude H. Sergievsky Professor of Neurology, Psychiatry, and Epidemiology
Chair & Neurologist-in-Chief, Department of Neurology
Director, Gertrude H. Sergievsky Center
Co-director, Taub Institute for Research on Alzheimer's Disease and the Aging Brain



DR. NICOLE SCHUPF



Genetic epidemiology of Down syndrome and Alzheimer disease.



DR. SCOTT SMALL



Correlations of memory and changes in the hippocampal formation using functional magnetic resonance imaging in normal aging and in Alzheimer disease. Parallel studies in transgenic mice.



DR. YAAKOV STERN



Experimental and neuroimaging approaches to cognitive issues in normal aging and diseases of the aging brain (including Alzheimer, Parkinson, and Huntington diseases). Current experimental cognitive studies include: source memory, working memory, priming, and the interplay between explicit recollection and familiarity in normal aging; basic timing mechanisms in normal aging and Parkinson disease; language and working memory in Alzheimer disease; and effects of literacy, education, ethnicity, and acculturation on neuropsychological task performance in cognitive neuroimaging. Cognitive neuroimaging studies include: network changes in mediating recognition and working memory and cognitive reserve in normal aging and Alzheimer disease (H2 15O PET and fMRI); age priming in young adults and normal aging (ER-fMRI) executive function in normal aging and Huntington disease (fMRI), and effects of estrogen on recognition and source memory in elderly women (ERP).



About Us || Our Doctors || Patient Information || Memory Evaluation || Neuropsychological Testing || Clinical Trials || Web Resources || Caregiver Support || Education and Training Opportunities || Research || Contact Us || Directions to the Neurological Institute || Sitemap
Copyright © 1997-2009 Center For Memory And Behavioral Disorders || The Neurological Institute of New York || At Columbia University Medical Center
710 W 168th Street, 3d Floor, New York, NY 10032 || Affiliated with New York-Presbyterian Hospital || Last updated: May 30, 2013 |
Comments